Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RNS® System Post-Approval Study in Epilepsy

NCT02403843 is registered in ClinicalTrials.gov with NeuroPace as lead sponsor.

NCT NCT02403843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02403843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RNS® System Post-Approval Study in Epilepsy
Lead sponsor
NeuroPace
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
January 31, 2026
Enrollment
345 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy